| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 539997 | Kwality Pharma Kwality Pharmaceuticals Ltd | 19-May-2026 | Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended March 31 2026. |
| 540073 | BLS Internat. BLS International Services Ltd | 19-May-2026 | BLS International Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended on March 31 2026 along with Audit Report of the Statutory Auditors thereon and Final Dividend for the Financial Year 2025-26 if any |
| 540190 | Franklin Indust. Franklin Industries Ltd | 19-May-2026 | Quarterly Results Franklin Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 19th May, 2026 at 4:00 P.M. at the Registered Office of the Company situated at A-207, Infinity Tower, Corporate Road, Prahalad Nagar, Satellite, Ahmedabad - 380 015, inter alia, to consider and discuss: 1. The Audited Financial Results of the Company for the Quarter and Year ended on 31st March, 2026 along with Auditor's Report. 2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting. |
| 540455 | Escorp Asset Mgt Escorp Asset Management Ltd | 19-May-2026 | Audited Results |
| 540725 | Share India Sec. Share India Securities Ltd | 19-May-2026 | Final Dividend & Audited Results Share India Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve In continuation of our earlier intimation dated May 12, 2026, the Board may also consider the proposal for early redemption of the Non-Convertible Debentures of the Company, as detailed in the attached document. (As Per BSE Annoncement Dated on:14.05.2026) |
| 540701 | Dishman Carbogen Dishman Carbogen Amcis Ltd | 19-May-2026 | Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on 31st March, 2026 and to consider, evaluate and approve the proposal of availing External Commercial Borrowing (ECB) in the form of unsecured loan(s) from a promoter group Company inter alia to refinance the existing external indebtedness of the Company, at more favourable terms, including reducing the interest cost, subject to approval of shareholders and other regulatory approvals, as applicable. |
| 541556 | Rites Rites Ltd | 19-May-2026 | RITES Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on March 31, 2026 and to consider recommendation of final dividend, if any on equity shares of the Company, for the Financial Year 2025-26. |
| 541557 | Fine Organic Fine Organic Industries Ltd | 19-May-2026 | Fine Organic Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve As enclosed |
| 541400 | Zim Laboratories Zim Laboratories Ltd | 19-May-2026 | Audited Results |
| 541445 | Waa Solar Waa Solar Ltd | 19-May-2026 | Waa Solar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Half year and Year ended on March 31, 2026. |



